HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Korinna Pilz Selected Research

BI 6727

3/2016Volasertib Versus Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: A Randomized Phase II Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire Study.
11/2015A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non-Small-Cell Lung Cancer.
10/2015A phase I study of volasertib combined with afatinib, in advanced solid tumors.
6/2015Phase I trial of volasertib, a Polo-like kinase inhibitor, plus platinum agents in solid tumors: safety, pharmacokinetics and activity.
4/2014An open-label, single-arm, phase 2 trial of the Polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Korinna Pilz Research Topics

Disease

4Neoplasms (Cancer)
03/2016 - 04/2014
2Pneumonia (Pneumonitis)
01/2022 - 12/2020
2COVID-19
01/2022 - 12/2020
1Infections
01/2022
1Inflammation (Inflammations)
12/2020
1Dyspnea (Shortness of Breath)
12/2020
1Ovarian Neoplasms (Ovarian Cancer)
03/2016
1Fatigue
11/2015
1Exanthema (Rash)
11/2015
1Nausea
11/2015
1Diarrhea
11/2015
1Neutropenia
11/2015
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2015
1Vomiting
11/2015
1Neoplasm Metastasis (Metastasis)
04/2014

Drug/Important Bio-Agent (IBA)

5BI 6727IBA
03/2016 - 04/2014
4PlatinumIBA
03/2016 - 04/2014
3Phosphotransferases (Kinase)IBA
10/2015 - 04/2014
2vilobelimabIBA
01/2022 - 12/2020
2AnaphylatoxinsIBA
01/2022 - 12/2020
2Monoclonal AntibodiesIBA
01/2022 - 12/2020
1EnzymesIBA
01/2022
1Complement System Proteins (Complement)IBA
12/2020
1Oxygen (Dioxygen)IBA
12/2020
1Pemetrexed (MTA)FDA Link
11/2015
1AfatinibIBA
10/2015
1Polo-Like Kinase 1IBA
06/2015
1Cisplatin (Platino)FDA LinkGeneric
06/2015
1Carboplatin (JM8)FDA LinkGeneric
06/2015
1Polo-like KinasesIBA
04/2014

Therapy/Procedure

3Therapeutics
03/2016 - 04/2014
2Drug Therapy (Chemotherapy)
03/2016 - 11/2015
1Aftercare (After-Treatment)
03/2016